Author details

Full Name

Johannes Gojo

Affiliation

ORCID

Career Start Year

2012

Papers

H Index

Expertise

CM4AI Collaborator

PMID	Paper Title	Journal Title	Published Year
36782314	CNS tumor with EP300::BCOR fusion: discussing its prevalence in adult population.	Acta Neuropathol Commun	2023
36308741	Viral infections in pediatric brain tumor patients treated with targeted therapies.	Pediatric Blood and Cancer	2023
36356895	Rare embryonal and sarcomatous central nervous system tumours: State-of-the art and future directions.	Eur J Med Genet	2023
35640920	Activation of Hedgehog signaling by the oncogenic RELA fusion reveals a primary cilia-dependent vulnerability in supratentorial ependymoma.	Neuro-Oncology	2023
36437415	Amplification of the PLAG-family genes-PLAGL1 and PLAGL2-isÂ a key feature of the novel tumor type CNS embryonal tumor with PLAGL amplification.	Acta Neuropathol	2023
37835571	The Site of Origin of Medulloblastoma: Surgical Observations Correlated to Molecular Groups.	Cancers (Basel)	2023
37883081	Sustained Survival Benefit in Recurrent Medulloblastoma by a Metronomic Antiangiogenic Regimen: A Nonrandomized Controlled Trial.	JAMA Oncol	2023
37020088	Clinical applicability of miR517a detection in liquid biopsies of ETMR patients.	Acta Neuropathol	2023
36951979	Placement of EVD in pediatric posterior fossa tumors: safe and efficient or old-fashioned? The Vienna experience.		2023
36694406	Reply to: Comment on: Viral infections in pediatric brain tumor patients treated with targeted therapies.		2023
37246492	Reply to: Comment on: Viral infections in pediatric brain tumor patients treated with targeted therapies.		2023
36740985	A whole-genome scan for Artemisinin cytotoxicity reveals a novel therapy for human brain tumors.	EMBO Mol Med	2023
37173990	Proof-of-Concept for Liquid Biopsy Disease Monitoring of <i>MYC</i>-Amplified Group 3 Medulloblastoma by Droplet Digital PCR.	Cancers (Basel)	2023
37165922	Good to know - This is PPIE! Development of a training tool for public and patient involvement and engagement in pediatric oncological research.		2023
36786841	Correction to: Amplification of the PLAG-family genes-PLAGL1 and PLAGL2-isÂ a key feature of the novel tumor type CNS embryonal tumor with PLAGL amplification.	Acta Neuropathol	2023
37494589	Bridging the gap: A quality improvement project to implement psychosocial care standards into clinical practice in pediatric oncology.	Klin Padiatr	2023
36471067	The landscape of tumor cell states and spatial organization in H3-K27M mutant diffuse midline glioma across age and location.	Nat Genet	2022
36291912	Improved Long-Term Survival of Patients with Recurrent Medulloblastoma Treated with a "MEMMAT-like" Metronomic Antiangiogenic Approach.	Cancers (Basel)	2022
36005159	Prospective Evaluation of Kidney Function in Long-Term Survivors of Pediatric CNS Tumors.	Current Oncology	2022
35484633	Fibroblast growth factor receptor 4 promotes glioblastoma progression: a central role of integrin-mediated cell invasiveness.	Acta Neuropathol Commun	2022
35355137	Pharmacokinetics of metronomic temozolomide in cerebrospinal fluid of children with malignant central nervous system tumors.	Cancer Chemotherapy and Pharmacology	2022
35401087	Unique Finding of a Primary Central Nervous System Neuroendocrine Carcinoma in a 5-Year-Old Child: A Case Report.	Frontiers in Neuroscience	2022
36575299	Drug sensitivity profiling of 3D tumor tissue cultures in the pediatric precision oncology program INFORM.	NPJ Precis Oncol	2022
34417833	PATZ1 fusions define a novel molecularly distinct neuroepithelial tumor entity with a broad histological spectrum.	Acta Neuropathol	2021
34077956	Therapeutic implications of improved molecular diagnostics for rare CNS embryonal tumor entities: results of an international, retrospective study.	Neuro Oncol	2021
34046693	Targeting fibroblast growth factor receptors to combat aggressive ependymoma.	Acta Neuropathol	2021
33879448	Cross-Species Genomics Reveals Oncogenic Dependencies in ZFTA/C11orf95 Fusion-Positive Supratentorial Ependymomas.	Cancer Discov	2021
33921303	Novel Insights into Diagnosis, Biology and Treatment of Primary Diffuse Leptomeningeal Melanomatosis.	J Pers Med	2021
33090244	Infiltrative gliomas of the thalamus in children: the role of surgery in the era of H3 K27M mutant midline gliomas.	Acta Neurochir (Wien)	2021
31065705	Predisposition of Wingless Subgroup Medulloblastoma for Primary Tumor Hemorrhage.	Neurosurgery	2020
32317288	Telomerase Reverse Transcriptase Promoter Mutations Identify a Genomically Defined and Highly Aggressive Human Pleural Mesothelioma Subgroup.	Clin Cancer Res	2020
32064608	Lipid droplet-mediated scavenging as novel intrinsic and adaptive resistance factor against the multikinase inhibitor ponatinib.	International Journal of Cancer	2020
32466393	Determination of a Tumor-Promoting Microenvironment in Recurrent Medulloblastoma: A Multi-Omics Study of Cerebrospinal Fluid.	Cancers	2020
32493453	Cerebrospinal fluid penetration of targeted therapeutics in pediatric brain tumor patients.	Acta neuropathologica communications	2020
33260839	Liquid Biomarkers for Pediatric Brain Tumors: Biological Features, Advantages and Perspectives.	Journal of Personalized Medicine	2020
33143299	p53 Loss Mediates Hypersensitivity to ETS Transcription Factor Inhibition Based on PARylation-Mediated Cell Death Induction.	Cancers (Basel)	2020
33353026	Cerebrospinal Fluid Penetration and Combination Therapy of Entrectinib for Disseminated <i>ROS1/NTRK</i>-Fusion Positive Pediatric High-Grade Glioma.	J Pers Med	2020
32738523	Evaluation and optimization of common lipid extraction methods in cerebrospinal fluid samples.	Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences	2020
32663469	Single-Cell RNA-Seq Reveals Cellular Hierarchies and Impaired Developmental Trajectories in Pediatric Ependymoma.	Cancer Cell	2020
33392079	Potential Importance of Early Focal Radiotherapy Following Gross Total Resection for Long-Term Survival in Children With Embryonal Tumors With Multilayered Rosettes.	Front Oncol	2020
31341285	Resolving medulloblastoma cellular architecture by single-cell genomics.	Nature	2019
31998633	Personalized Treatment of H3K27M-Mutant Pediatric Diffuse Gliomas Provides Improved Therapeutic Opportunities.	Frontiers in Oncology	2019
31561218	Cerebrospinal fluid disturbances after transcallosal surgery: incidence and predictive factors.	Journal of Neurosurgery	2019
31541075	High impact of miRNA-4521 on FOXM1 expression in medulloblastoma.	Cell Death Dis	2019
31391125	TERT expression is susceptible to BRAF and ETS-factor inhibition in BRAF/TERT promoter double-mutated glioma.	Acta neuropathologica communications	2019
31345789	Epigenomics and Single-Cell Sequencing Define a Developmental Hierarchy in Langerhans Cell Histiocytosis.	Cancer Discov	2019
29674595	Developmental and oncogenic programs in H3K27M gliomas dissected by single-cell RNA-seq.	Science	2018
30010853	TERT promoter mutations are associated with poor prognosis and cell immortalization in meningioma.	Neuro Oncol	2018
28577293	Pharmacokinetics of Bevacizumab in Three Patients Under the Age of 3Â Years with CNS Malignancies.	Drugs in R and D	2017
28371821	Telomerase activation in posterior fossa group A ependymomas is associated with dismal prognosis and chromosome 1q gain.	Neuro Oncol	2017